Clinical course of chagas' heart disease: A comparison with dilated cardiomyopathy

International Journal of Cardiology

Volumn 60, Issue 2, 1997, Pages 187-193

  Bestetti, Reinaldo B ^a   Muccillo, Gerson ^a  

^a Serviço de Saude PCARP   (Brazil)

Author keywords

Cardiomyopathy; Chagas' cardiomyopathy; Dilated; Heart failure; South America; Trypanosomiasis

Indexed keywords

ADULT; AGED; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; HEART DILATATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; BRAZIL; CARDIOMYOPATHY, DILATED; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0030738323     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00083-1     Document Type: Article

References (35)

1. World Health Organization Control of Chagas' disease. WHO Tech Rep Ser 1991;811:27.
2. Rossi MA, Bestetti RB. The challenge of chagasic cardiomyopathy. Cardiology 1995;86:1-7.
3. Bestetti RB, Dalbó CMR, Freitas OC, Teno LAC, Castilho OT, Oliveira JSM. Noninvasive predictors of mortality for patients with Chagas' heart disease: a multivariate stepwise logistic regression study. Cardiology 1994;84:61-267.
4. Bestetti RB, Dalbó CMR, Arruda CA, Correia-Filho D, Freitas OC. Predictors of sudden cardiac death for patients with Chagas' disease: a hospital-derived cohort study. Cardiology 1996;87:481-7.
5. Bestetti RB, Ariolli MT, Carmo JL et al. Clinical characteristics of acute myocardial infarction in patients with Chagas' disease. Int J Cardiol 1992;35:371-6.
6. Porto CC. O eletrocardiograma no prognóstico e evolução da doença de Chagas. Arq Bras Cardiol 1964;17:313-46.
7. Oliveira JSM, Oliveira JAM, Frederigue-JR U, Lima-Filho EC. Apical aneurysm of Chagas' heart disease. Br Heart J 1981;46:432-7.
8. de Paola AAV, Horowitz L, Miyamoto MH et al. Angiographic and electrophysiologic substrates of sustained ventricular tachycardia in chronic chagasic myocarditis. Am J Cardiol 1990;29:39-46.
9. Bestetti RB, Freitas OC, Muccillo G, Oliveira JSM. Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas' disease. Eur Heart J 1993;14:1610-4.
10. Oliveira JSM. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Am Heart J 1985;110:1092-8.
11. Ramos SG, Maturri L, Rossi L, Rossi MA. Lesions of mediastinal paraganglia in chronic chagasic cardiomyopathy: cause of sudden death?. Am Heart J 1996;131:417-20.
12. Milei J, Storino R, Alonso GF, Beigelman R, Vanzulli S, Ferrans VJ. Endomyocardial biopsies in chronic chagasic cardiomyopathy. Cardiology 1992;80:424-37.
13. Barreto ACP, Higuchi ML, da Luz PL et al. Comparação entre alterações histológicas da miocardiopatia da doença de Chagas e cardiomiopatia dilatada. Arq Bras Cardiol 1989;52:79-83.
14. Bestetti RB, Rossi MA. A rationale approach for mortality risk stratification in patients with Chagas' heart disease. Int J Cardiol 1997;58:199-209.
15. Fisch C. Electrocardiography. In: Braunwald E, editor. Heart disease. A textbook of Cardiovascular Medicine. Philadelphia: WB Saunders Company, 1997;108-152.
16. Acquatella H, Schiller N, Puigbó JJ et al. M-mode and two-dimensional echocardiography in chronic Chagas' heart disease. Circulation 1980;62:787-99.
17. Kasper EK, Agema WRP, Hutchins GM, Deckers JW, Hare JS, Baughman KL. The causes of dilated cardiomyopathy: a clinicopathologic review of 637 consecutive patients. J Am Coll Cardiol 1994;23:586-90.
18. Andersson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993;126:632-40.
19. Bocchi E. Situação atual das indicaçóes e resultados do tratamento cirurgico da insuficiência cardíaca. Arq Bras Cardiol 1994;63:523-30.
20. Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol 1992;70:1180-4.
21. van Veldhuisen DJ, Brouwer J, Man in t'Veld AJ, Dunselman PHJM, Boomsma F, Lie KI. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. Am J Cardiol 1995;75:796-800.
22. SOLVD investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
23. Kleber FX, Niemoller L, Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J 1992;67:289-96.
24. Carson P, Johnson G, Fletcher R, Cohn J. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT). J Am Coll Cardiol 1996;27:642-9.
25. van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman MLJ, Hillege H, Lie KI. Comparison between New York Heart Association Classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1992;70:359-63.
26. SOLVD investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
27. Grandman A, Deedwania P, Cody R et al. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989;14:564-70.
28. Bittner V, Weiner DH, Yusuf S et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. J Am Med Assoc 1993;270:1702-7.
29. van Veldhuisen DJ, Man in't Veld AJ, Dunselman PHJ et al. Double-blind placebo controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: Results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol 1993;22:1564-73.
30. Newman TJ, Maskin CS, Dennick LG, Meyer JH, Hallows BG, Cooper WH. Efects of captopril on survival in patients with heart failure. Am J Med 1988;84(Suppl 3A):140-4.
31. Littler WA, Sheridan DJ. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. Br Heart J 1995;73:428-33.
32. Packer M, Bristow M, Cohn J et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
33. Casado J, Davila DF, Donis JH et al. Electrocardiographic abnormalities and left ventricular systolic function in Chagas' heart disease. Int J Cardiol 1990;28:35-41.
34. Roberti RR, Martinez EE, Andrade JL et al. Chagas' cardiomyopathy and captopril. Eur Heart J 1992;13:966-70.
35. Anguita M, Arizon JM, Bueno G et al. Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1993;72:413-7.